Newswriter.ai

Curated Business & Technology News from Around the Internet

FDA Clears Starlight Therapeutics' IND Application for Glioblastoma Treatment Trial FEATURED

FDA Clears Starlight Therapeutics' IND Application for Glioblastoma Treatment Trial

Starlight Therapeutics, under Lantern Pharma, receives FDA clearance for a Phase Ib/2a clinical trial of STAR-001 combined with spironolactone, offering new hope for glioblastoma multiforme patients.
Source August 6, 2025
Read More

Showing 28 of 4036 articles (Page 121 of 145)